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The class  II  major histocompatibility antigens,  termed  Ia in  the mouse, are 
genetically polymorphic glycoprotein heterodimers.  Although recent evidence 
suggests that these glycoproteins are responsible for mediating immune response 
(Ir) l gene effects (1, 2), the mechanism(s) through which Ia antigens regulate Ir 
gene  function  is  still  not  understood.  One  approach  designed  to  address  this 
issue  is  to  obtain  detailed  information  on  the  structure  of these  antigens  to 
determine  what  structural  features  can  account  for  the  observed  biological 
properties of Ia. Newly developed techniques in molecular biology have allowed 
rapid advances in our knowledge of the primary structure of the class II gene 
products (3-5).  This methodology does not,  however, provide  information on 
the structural features of Ia that are generated posttranslationally, features that 
may play a role in Ir gene function or in regulation of Ia antigen expression. 
One of the notable properties of Ia molecules, detectable by isoelectric focusing 
analysis, is a  high degree of charge heterogeneity (6). Generally, charge hetero- 
geneity of glycoproteins is attributed to variable amounts of sialic acid on  the 
terminal  sugars  of the  carbohydrate  moieties of the  glycoproteins.  However, 
neuraminidase treatment of Ia does not totally eliminate the charge heterogeneity 
of Ia a  and/3 chains (7, 8), indicating either that some sialic acid residues are not 
sensitive to the treatment or that other charged residues are present in variable 
amounts. 
It has recently been discovered that mammalian glycoproteins can be sulfated 
and thus sulfation can be included among the modifications conferring charge 
on these molecules. Sulfate has been identified on both O- and N-linked carbo- 
hydrate groups of glycoproteins (9-12), as well as in direct linkage to amino acid 
residues (13).  We began the following experiments to determine whether some 
of the charge heterogeneity of Ia could be due to posttranslational addition of 
sulfate to la a  or 13 chains.  We were unable to detect sulfation of conventional 
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Ia glycoproteins, but in the course of these experiments we did detect a  hereto- 
fore undescribed component of the Ia antigen complex. 
Materials and Methods 
Mice.  Mice were obtained from the animal facility of the Jewish Hospital of St.  Louis, 
St. Louis, MO, and were used at 8-12 wk of age. 
Antibodies.  A.TH anti A.TL (aI  k) and (129×A.TL)Fj  a  A.AL (aK  k) alloantisera were 
produced and supplied by Dr. D. Shreffler, Washington University, St. Louis, MO. The 
monoclonal antibody 10-2.16 (anti-Ia. 17, used as an anti I-A  k reagent) was obtained from 
the  10-2.16  cell  line  (14),  supplied  by the  Salk  Institute.  MKD6  (anti  I-A  d)  (15)  was 
originally obtained from Drs. P. Marrack andJ. Kappler of the National Jewish Hospital, 
Denver, CO.  The Do 3 monoclonal antibody was developed by Drs.  M.  Nahm and V. 
Hauptfeld, Washington University, St. Louis, MO (16). It reacts with the Ia.7 specificity 
in  cytotoxicity  assays,  2 and  it  precipitates  I-E  glycoproteins  (S.  Cullen,  unpublished 
observations).  In-l,  a  rat  anti-mouse  invariant  chain  monoclonal  antibody  (17),  was 
produced and generously provided by G. Hammerling, Deutches Krebsforschungzentrum, 
Heidelberg, Germany. Rabbit anti-rat Ig serum was purchased from Cappel Laboratories, 
West Chester, PA. 
Biosvnthetic Labeling.  A spleen cell suspension was prepared and the splenocytes were 
washed twice in phosphate-buffered saline (PBS, pH 7.2) containing 1% dialyzed fetal calf 
serum (dFCS). Before biosynthetic labeling, cells were preincubated in precursor-deficient 
medium  for  30-45  min  at  37°C,  then  pelleted  by centrifugation  and  resuspended  in 
medium containing the radioactive precursor. The medium used for [~SS]sulfate labeling 
was Earle's balanced salt solution (with MgCI~ substituted for MgSO4) supplemented with 
amino acids and  vitamins from an  RPMI Select-amine kit (Gibco Laboratories, Grand 
Island, NY), glutamine, 10 mM Hepes, 5.0% dFCS, and aqueous 35SO4 (1,100-1,300 Ci/ 
mmole; Amersham Corp., Arlington Heights, IL at 200-500 t~Ci/ml. For [35S]methionine 
or ['~H]leucine labeling, the medium used was RPMI 1640 lacking methionine or leucine, 
supplemented as above with  glutamine,  Hepes, and  dFCS.  [3"~S]Methionine (>800  Ci/ 
mmole, Amersham Corp.) was used at 300 #Ci/ml and [3H]leucine (130-190 Ci/mmole, 
Amersham Corp.) was used at 250-350 #Ci/ml). In all cases, cells were labeled at a density 
of 5-t0 ×  10  ~ cells/ml for 3-5 h in a 37°C humidified atmosphere containing 7.0% CO~. 
After  labeling,  cell  suspensions  were  diluted  in  complete  RPMI  1640,  collected  by 
centrifugation and cell pellets were either solubilized immediately or frozen at -80°C. 
Solubilization,  Immune  Precipitation,  and Electrophoresis.  Radiolabeled cells were solubi- 
lized at a  density of 2-3  ×  10 v cells/ml in  0.5%  NP-40 (Non-Idet P-40,  Particle Data, 
Inc., Elmhurst, IL) in PBS pH 7.2 containing the protease inhibitors phenylmethylsulfonyl 
fluoride (PMSF) (200 #g/ml), L-l-tosylamide-2-phenylethyl chloromethyl ketone (TPCK) 
(50  /~g/ml)  and  N-a-p-tosyI-L-lysine chloromethyl  ketone  (TLCK)  (50  /~g/ml)  (Sigma 
Chemical Co., St. Louis, MO). After thorough mixing and incubation at 4°C for 45 min, 
the cell extracts were centrifuged at 100,000 g for 60 min at 4°C. The supernatant was 
collected and used as a source of la antigens in immunoprecipitations. Before immuno- 
precipitation, NP-40 lysates were pretreated once with fixed protein A-bearing Staphylo- 
coccus aureus Cowan strain I (SaCI) (18) to remove endogenously labeled IgG, twice with 
normal serum and SAC1, and finally with SaCI alone to decrease nonspecific adsorption 
in immunoprecipitates. Aliquots of pretreated cell lysates were incubated with antisera or 
monoclonal antibodies overnight at 4°C. Antigen-antibody complexes were isolated either 
with SaCI alone (alloantisera, 10-2.16, MKD6, Do3) or rabbit anti-rat Ig-SaCI immunoad- 
sorbants (In-l). After 30 min at 4°C, the complexes were collected by centrifugation at 
2,500 g, and washed four times with PBS containing 0.25% NP-40 (PSN). 
Radiolabeled antigen was dissociated from antibody and SaCI by boiling for 2 min in 
SDS elution  buffer (2%  SDS,  62  mM  Tris,  pH 6.8)  containing  2%  2-mercaptoethanol 
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unless otherwise indicated. Samples were analyzed by slab gel electrophoresis in a modified 
Laemmli-Maizei discontinuous SDS-PAGE system (18) using 10% polyacrylamide running 
gels and 4% polyacrylamlide stacking gels.  Molecular weights were estimated from the 
position  of co-electrophoresed  ~4C-labeled  standard  proteins  including  bovine  serum 
albumin (mol wt 69,000)  IgG (mol wt 55,000  and 25,000),  ovalbumin (mol wt 46,000) 
and carbonic anhydrase (mol wt 30,000) purchased from New England Nuclear, Boston, 
MA. 
Two-dimensional separations (2D-PAGE) were performed as generally described  by 
O'Farrell (19), with some modifications (20). The first dimension separation by isoelectric 
focusing (IEF) was performed in  5-mm ×  130-mm cylindrical gels containing 4.0% pH 
3.5- I 0 Ampholines (LKB Instruments, Rockviile, MD). Samples were electrophoresed at 
0.8 W/gel until the voltage reached 800 V, then under constant voltage (800 V) for 16 
h, and then at 1,200 V for the final hour. The pH gradient was determined by measuring 
the pH of 1-cm slices of a blank gel run in parallel with the samples. The IEF gels were 
equilibrated in SDS, embedded in agarose on the top of a slab gel (3-cm 4% acrylamide 
stacking gel and  13-cm  11% acrylamide running gel) and electrophoresed as described 
previously (20). 
Protease Treatments.  Staphylococcal V8 protease (S. aureus  V8 lot  13) was purchased 
from Miles Laboratories (Elkhart, IN). A  1 mg/ml stock solution of enzyme was prepared 
in SDS elution buffer and added to SDS eluates of immunoprecipitates at a final concen- 
tration of 125 #g/ml.  Enzyme-treated and untreated control samples were incubated at 
37°C  for 2  h,  then  placed in  a  boiling water bath for 2  min to inactivate enzyme. 2- 
Mercaptoethanol was added to a final concentration of 2% and samples were immediately 
electrophoresed on 10% SDS-PAGE slab gels. 
For pronase digestion,  eluates of SaCI immunoprecipitates were precipitated with  3 
volumes of 95% ethanol containing 1.3% potassium acetate at -20°C (21). Carrier protein 
was included at a final concentration of 1 mg/ml and precipitation was allowed to proceed 
overnight at -20°C. The 4,100 g pellets were washed three times in 95% ethanol,  1.3% 
potassium acetate,  once  in  absolute ethanol,  and  were  then  dried  overnight at  37°C. 
Ethanol  precipitates were  solubilized  in  0.5  ml  of  10  mM  Tris,  1 mM  CaCI2,  pH  8. 
Predigested  pronase  (S.  griseus  protease,  lot  202867;  Calbiochem-Behring  Corp.,  San 
Diego, CA) was added to a final concentration of 5 mg]ml. Samples were incubated in a 
toluene atmosphere at 50°C for 12 h, a second aliquot of pronase equivalent to the first 
was added, and digestion was allowed to continue for an additional 12 h. A control sample 
was incubated in the digestion buffer in the absence of enzyme for 24 h at 50°C. After 
digestion, samples were boiled for 2 min to inactivate enzyme and either used directly or 
stored at -80 o  C. 
Bio-Gel P-IO Chromatography.  Pronase-treated samples (0.5 ml) were applied to a Bio- 
Gel P-10 (Bio-Rad Laboratories, Richmond, California) column (-400 mesh, 40-cm ×  1- 
cm) equilibrated in 0.1  M ammonium bicarbonate. The column was eluted with the same 
buffer at a flow rate of 1.5 ml/h. Fractions of 0.9 ml were collected and the radioactivity 
in an aliquot from each fraction was determined. Void (Vo) and included (Vi) volumes 
were determined for each column run by monitoring hemoglobin (Vo) and mannose (Vi), 
which were added to each sample before application to the column. Bio-Gel P-10 has an 
exclusion limit of 20,000 for globular proteins. 
Alkaline Borohydride Treatment.  An aliquot of the ssSO4-1abeled fraction peak obtained 
by Biogel-P-10 chromatography of pronase-digested material was lyophilized to dryness, 
resuspended in 1.0 ml hydrolysis buffer (0.05 M NaOH, 5 ×  10 -~ M N-acetyl-glucosamine,. 
1 M NaBH4) and incubated at 45°C for 16 h (22).  Acetic acid was then added dropwise 
to neutralize the sample. Sodium ions were removed by passing the solution over a 2-ml 
column of activated Dowex AGWX8  (Bio-Rad  Laboratories) and borate ions were re- 
moved by evaporating the Dowex column effluent three times with methanol. The dried 
sample was resuspended in 0.1  M ammonium bicarbonate, reconstituted with hemoglobin 
(2 rag) and mannose (2 mg) and rechromatographed on the Bio-Gel P-10 column. 
Chondroitinase  Digestion.  Immunoprecipitated  material  from  ~sSO4-1abeled  B10.A 
spleen  cells  was  digested  with  pronase  and  chromatographed  on  Bio-Gel  P-10.  Peak 1982  A  NEW  COMPONENT  IN  THE  MURINE  la  MOLECULAR  COMPLEX 
fractions,  eluting  in  the  void  volume,  were  pooled and  lyophilized  to  dryness,  then 
resuspended in 50 mM Tris-HCl, pH 8, containing  0.1 mg/ml BSA. Chondroitinase  AC 
(Miles Laboratories) was added at a  final  concentration  of 1 U/ml and digestion  was 
carried out for 14 h at 37°C.  Chondroitin sulfate (Sigma Chemical Co.) was digested in 
parallel  as a  positive  control  for the efficacy of digestion.  Mock treated and  enzyme- 
digested samples were boiled for 2 min and then rechromatographed on Bio-Gel P-10. 
Paper Chromatography.  Chondroitinase AC-digested samples were spotted on What- 
man  no.  I  paper  (American  Scientific  Products)  and  analyzed  by descending  paper 
chromatography using a solvent system of 1-butanol, glacial acetic acid, and 1 N NH4OH 
(2:3:1). Disaccharide  standards run in adjacent lanes included 2-acetamido-2-deoxy-3-0- 
(B-D-gluco-4-enepyranosyluronic acid)-4-O-D  galactose (A-Di-4S), 2-acetamido-2-deoxy-3-O- 
(/3-D-gluco-4-enepyranosyluronic acid)-6-O-sulfo-~galactose  (A-Di-6S) and 2-acetamido-2- 
deoxy-3-O-(/J-D-gluco-4-enepyranosyluronic acid)-D-galactose (A-Di-OS). 
Results 
A Novel [~5S]Sulfate-Labeled Component Coprecipitated with Ia.  To determine 
whether Ia glycoproteins are sulfated, splenocytes from B 10.A mice were divided 
into  two  groups  and  biosynthetically  labeled  either  with  [SH]leucine  or  with 
:~5SO4. After labeling,  cell pellets were solubilized in 0.5%  NP-40, and aliquots 
of the cell lysates were immunoprecipitated with several alloantibodies (Fig.  1 A). 
H-2K  k and  Ia k glycoproteins  labeled with  [~H]leucine are  shown in  lanes 2-4. 
When  gel  profiles  of  immunoprecipitates  prepared  from  [~SS]sulfate-labeled 
spleen  cells  were  analyzed,  two  observations  were  made.  First,  there  was  no 
detectable labeled band  in  the anti-H-2K  immunoprecipitate  (lane  6).  Second, 
anti-Ia  immunoprecipitates  from  35SO4-1abeled  spleen  cells did not contain  la- 
beled bands in the region of the gel where Ia a  and/3 or associated invariant (Ii) 
glycoproteins migrate.  Instead, a labeled band of considerable molecular weight 
heterogeneity was seen,  spanning  the  46-69,000  dalton  (46-69  kd) region  of 
the gel.  This material  was detectable only in the immunoprecipitates  prepared 
with an anti-Ia alloantiserum (lane 8) and with an anti-I-A k monocional antibody 
(lane 7), and was not found in the normal serum control (lane 5). We confirmed 
and extended these observations in the following two experiments. 
B10.BR spleen  cells  were  labeled  with  [35S]sulfate  and  immunoprecipitates 
from the  NP-40 cell lysate were examined  (Fig.  1 B).  The  monocional anti-I-A 
antibody precipitated  a  band similar to that  seen with  B10.A splenocytes (lane 
5).  In addition,  when a  monoclonai anti-I-E antibody was used for immunopre- 
cipitation,  the same type of band was detectable (lane 6).  Analysis of immuno- 
precipitates prepared with SaCI alone to precipitate endogenous IgG, or with an 
anti H-2K alioantiserum showed no detectable [35S]sulfate-labeled bands (lanes 1 
and  3).  Control  precipitates  employing  normal  mouse  serum  (NMS)  or  an 
irrelevant  monoclonal antibody were also negative (lanes 2 and 4).  The results 
of a second experiment using B 10.A spleen cells are shown in Fig.  1 C. The 46- 
69-kd component was not only seen  in  immunoprecipitates  prepared  with  the 
monoclonal anti-I-A and -I-E reagents (lanes 2 and 3), but also in an immunopre- 
cipitate prepared with a monoclonal anti-invariant chain reagent (lane 5). Control 
precipitates prepared with an irrelevant monoclonal antibody or with the rabbit 
anti-rat Ig developing reagent (lanes 1 and 4) were negative. In other experiments 
(not shown), SDS gel analysis of 35SO4-1abeled  B10.A immunoprecipitates  pre- 
pared with rabbit anti-mouse Ig or anti-H-2D  a alloantisera also do not show any SANT  ET  AL.  1983 
FIguRE  1.  SDS-PAGE identifies a 46-69,000-dalton ssSO4-1abeled component precipitated 
by anti-Ia reagents. (A) [35S]Methionine-labeled  (lanes 1-4)  or 35SO4-1abeled  (lanes 5-8) B 10.A 
spleen cell extracts were precipitated with normal mouse serum (lanes 1 and 5), anti-H-2K  k 
alloantiserum (lanes 2  and  6),  anti-I-A  k monoclona] antibody (lanes  3  and  7)  and  anti-I  k 
35  alloantiserum (lanes 4 and 8). (B) A  SO4-1abeled B10.BR spleen cell extract was precipitated 
with protein-A bearing Staphylococci only (lane 1), normal mouse serum (lane 2), anti-H-2K  k 
alloantiserum (lane 3),  control anti-I-A  d monoclonal antibody (lane 4), anti-I-A  k monoclonal 
antibody (lane 5), and anti-I-E  k monoclonal  antibody (lane 6). (C) A 35SO4-1abeled  B 10.A spleen 
d  k  cell  extract  was  precipitated with control anti-I-A  monoclonal antibody (lane 1), anti-I-A 
monocIonal antibody (lane 2), anti-I-E  k monoclonal antibody (lane 3), control rabbit anti-rat 
Ig-SaC1  immunoadsorbent (lane 4), and anti-Ii monoclonal antibody plus rabbit anti-rat-Ig- 
SaCI (lane 5). 
labeled bands. 
The results of the experiments shown in Fig.  1 indicate that immunoprecipi- 
tates  prepared  with  antibodies  specific  for  components  of the  Ia  molecular 
complex contain not only a,/3 and Ii, chains but also an additional sulfate-bearing 
molecule, of marked molecular weight heterogeneity. This molecule appears to 
be specifically associated with Ia since it was not precipitated in association with 
other spleen cell proteins, such as immunoglobulin or class I MHC antigens. 
To establish that the 46-69-kd molecule is expressed in mice of different H-2 
haplotypes, spleen  cells from  H-2  b,  H-2  d,  and  H-2  s mice were biosynthetically 
labeled with ~5SO4, and lysed with NP-40. Labeled molecules were immunopre- 
cipitated with the anti-invariant chain monoclonal antibody. The results shown 
in Fig. 2 demonstrate that these other haplotypes do indeed express the 46-69- 
kd molecule. 
In the preceding experiments, immunoprecipitates were analyzed by electro- 
phoresis in the presence of reducing agents. In order to determine whether the 
46-69-kd product was covalently associated with Ia glycoproteins, we compared 
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FIGURE  2.  SDS-PAGE analysis of anti-li  immunoprecipitates from mice of different  H-2 
haplotypes. Spleen cells from B10.A (lane 1), B10.S (lanes 2 and 3) B10.D2 (lanes 4 and 5) or 
•  $5  C57BL]10 (lanes 6 and 7) mice were biosynthetically labeled with  SO4 and lysed with NP- 
40. Lysates were immunoprecipitated with either RaRlg alone (lanes 2, 5, and 7) or anti-I~ 
and RaRlg (lanes I, 3, 4, and 6). [~H]Leucine-labeled  BI0.S RaRIg (lane 8) and anti-Ii (lane 
9) immunoprecipitates are shown for comparison. 
FICURE  3.  SDS-PAGE  of [3H]leucine  and 3~SO4-1abeled  B10.A I-A immunoprecipitates with 
and  without  2-mercaptoetbanol.  Precipitates in  lanes 1-4  were  treated  with 2-ME while 
precipitates in lanes 5-8 were untreated. Control precipitates (lanes I, 3, 5, and 7) employed 
an irrelevant monoclonal anti-l-A  d reagent, and specific  precipitates (lanes 2, 4, 6, and 8) used 
monoclonal anti-l-A  k  antibody• 
the presence or absence of 2-mercaptoethanol (Fig. 3). A comparison of reduced 
(lane 2) and nonreduced (lane 6) [~H]ieucine-labeled immunoprecipitates dem- 
onstrates  that  a,  /3,  and  Ii  chains  undergo  only  minor  mobility  shifts  upon 
reduction,  which  is expected from cleavage of intrachain  disulfide bonds.  The 
relative mobility of the 3"~SO4-1abeled component was the same in the presence 
(lane  4)  and  absence  (lane  8)  of 2-ME,  indicating  that  the  interaction  of this 
molecule with  a,/3,  and/or  Ii  chains is noncovalent. These results also demon- 
strate  that  the  46-69-kd  product  is  not  a  disulfide-linked  subunit  of a  larger 
molecular weight species. 
Biochemical Characteristics  of the 46-69-kd Molecule.  Despite the prominence of 
the 46-69-kd component in precipitates from [35S]sulfate-labeled spleen cells, no 
specific [3"~S]methionine- or [SH]leucine-labeled bands were detectable in the 46- 
69-kd region in SDS gel analysis of Ia or Ii immunoprecipitates. There are several 
possible explanations that could account for our inability to detect specific bands 
labeled  with  amino  acid  precursors  by  this  method.  If the  [~SS]sulfate-labeled 
component contains protein, it may constitute a  very minor percentage of total 
spleen cell  proteins.  Because  no  purification  steps  were performed before im- SANT  ET  AL.  1985 
munoprecipitation, such a minor species could readily be obscured by the proteins 
that generally contaminate immune precipitates of this type. Alternatively, the 
turnover time of the 35SO4-bearing protein could be slow relative to that of Ia 
and  Ii  glycoproteins  and  thus  it  would  be  poorly  labeled  with  [~H]- 
leucine or  [35S]methionine under the  relatively  short-term  labeling conditions 
used. A  third possibility is that the material may be proteoglycan in nature, and 
therefore it  would have only a  small, and thus poorly labeled,  protein core to 
which sulfated carbohydrate chains are covalently attached.  Finally, the 46-69- 
kd band could be a sulfated polysaccharide that is totally devoid of protein. We 
addressed some of these possibilities in the following experiments. 
To determine whether the 49-69-kd  component is  labeled with [3H]ieucine 
or [~'~S]methionine but is masked by other labeled proteins, we analyzed Ia and 
Ii immunoprecipitates by two-dimensional gel electrophoresis (2D-PAGE)  (Fig. 
4).  Fig. 4, A and B shows 2D gels of the 35SO4-1abeled  Ia and Ii immunoprecipi- 
tates. Two major sulfate-labeled species, distinguishable by charge and apparent 
molecular  weight,  were  observed  in  both  Ia  and  Ii  immunoprecipitates.  One 
component was detected as a  very diffuse spot, migrating between pH  4.2 and 
5.0 and  molecular weight 40-50  kd.  The other component was less heteroge- 
FIGURE 4.  2D-PAGE analysis of [sSS]methionine/[SH]leucine and  SSso4-1abeled I-A and  Ii 
immunoprecipitates from B10.A spleen cells, ssSO4-1abeled  I-A (panel A) and Ii (panel B) are 
compared to 35S-metpH-leu  I-A (panel C) and  Ii (panel D). Control panels (E and F) show 
precipitates made from sSS-met/SH-leu labeled material with rabbit anti-rat immunoglobulin 
(panel E) or with an irrelevant (anti I-A  d) monoclonal antibody (panel F). The control s~SO4 
precipitates (not shown) were negative. 1986  A  NEW  COMPONENT  IN  THE  MURINE  Ia  MOLECULAR  COMPLEX 
neous in charge,  with a pI of -~6.0 and was of slightly higher average  molecular 
weight than  the pI 4.2-5  species. 
When  these  gels  were compared  with  those  from  the  [SH]leucine-  and  [35S]- 
methionine-labeled  anti  I-A and  Ii immunoprecipitates  (Fig.  4, C and D, respec- 
tively), specific spots corresponding  to the more acidic sulfate-labeled spots were 
detected  in  both  Ii and  I-A  immunoprecipitates  (brackets)  upon  long  exposure 
of the  gel  to film,  indicating  that  this  sulfate-labeled  component  contains  poly- 
peptide  components.  The  more  basic  species  is  easily  detectable  in  the  [35S]- 
methionine-  and  [3H]leucine-labeled  Ii immunoprecipitate  (arrow),  but was not 
detected in the [35S]methionine- and [SH]ieucine-labeled  I-A immunoprecipitate. 
We  have  found  that  visualization  of the  more  basic  species  to  be  somewhat 
variable, although  the reason  for this is not clear at this time. 
To  further  establish  that  all  the  35SO4-1abeled  immunoprecipitated  material 
contains  protein,  Ia and  Ii  immunoprecipitates  from a  3~SO4-1abeled B10.A cell 
lysate were subjected to degradation  by S.  aureus  V8 protease,  which cleaves at 
glutamyl  and  aspartyl  residues  (23).  14C-BSA  and  laC-bovine  gamma  globulin 
were treated  in  parallel  as positive  controls  for digestion.  Protease-treated  and 
mock-digested  untreated  samples  were then  electrophoresed  on  10%  SDS gels 
(Fig.  5).  Lanes  1, 3, 5, and  7 show the mock-digested  14C-BSA, t4C-BGG, SSso4- 
I~, and 35SO4-I-A immunoprecipitates,  respectively. Lanes 2, 4, 6, and 8 show the 
enzyme-treated  samples.  Both  the anti-Ii-  and  anti-I-A-precipitated  [SSS]sulfate- 
labeled products were reduced in apparent  molecular weight by the V8 protease 
treatment,  indicating  that  both  3~SO4-1abeled components  seen  on  the  2D  gels 
contain  protein.  The  material  remaining  after  V8  digestion  continued  to have 
heterogeneous  mobility, but was all below 40 kd in apparent  molecular weight. 
We wished to gain  further  information  on the chemical  nature  of the 46-69- 
kd sulfated component of Ia and I~ precipitates.  In particular,  we were interested 
in  the  manner  in  which  sulfate was linked  to this  molecule and to what  class of 
macromolecules  it belonged.  Sulfate may be attached  to biological  molecules in 
several  different  ways.  Proteoglycans  contain  sulfate  groups  O- or  N-linked  to 
sugar  residues  of large  glycosaminoglycan  side  chains,  which  in  turn  are  cova- 
lently attached  to the core protein  (reviewed in reference  24).  Recently, sulfate 
FIGURE 5.  Treatment  of the ssSO4-1abeled  component with Staphylococcal  V8 protease, t4C- 
Labeled BSA without V8 treatment  (lane 1) is reduced to low molecular weight species after 
digestion (lane 2). Similarly 14C-labeled IgG without V8 treatment  (lane 3) is reduced to low 
molecular species after digestion (lane 4). The ssSO4-1abeled  components precipitated by anti- 
Ii (lane 5) or anti-Ia (lane 7) are reduced in apparent  molecular weight by V8 protease (lanes 
6 and 8. resnectivelv) from 46-69.000 to <40.000. SANT  ET  AL.  1987 
has been  identified on sugar residues of O- and  N-linked oligosaccharides on 
mammalian  glycoproteins (9-12)  and  has  also  been  found  linked  directly to 
amino acid residues of proteins (13). Several features of the 46"69-kd molecule, 
including  its  heterogeneity in  molecular weight  by  SDS-PAGE  and  its  poor 
incorporation of amino acid precursors, suggested that it might be proteoglycan 
in nature. We investigated this possibility in the following experiment. An NP- 
40 lysate of [~S]sulfate-labeled B10.A spleen cells was immunoprecipitated with 
the  monoclonal anti-invariant  antibody and  the  immunoprecipitated material 
was subjected to exhaustive pronase treatment. We then analyzed the pronase 
digest  by  gel  filtration  on  Bio-Gel  P-10  to  determine  whether  sulfate  was 
associated with the released amino acids or small peptides, or remained associated 
with a  larger pronase-resistant  moiety (Fig.  6).  A  single radioactive peak  was 
recovered, eluting in the void volume of the column. This result was suggestive 
evidence that the sulfate-bearing moiety was a  relatively large macromolecule, 
since amino acids and conventional glycopeptides bearing O- or N-linked oligo- 
saccharide  groups  would  be  found  in  the  included  volume  of the  column. 
However, we did consider the possibility that the sulfated material was pronase 
resistant because it contained clusters of serine or threonine residues to which 
small O-linked sulfated carbohydrate groups were attached. Such structures have 
been reported  to  be  pronase  resistant  (22,  25).  To  address this  question,  we 
treated an aliquot of the pronase-resistant P-10 pool with alkaline borohydride 
under conditions that would release O-linked carbohydrate groups by 3-elimi- 
nation. When the treated sample was rechromatographed on the Bio-Gel P-10 
FIGURE 6.  Bio-Gel P-10 chromatography of pronase and alkaline borohybride treated SSSO4- 
labeled component,  s'%O4-1abeled  BI0.A  spleen cell lysate precipitated  with anti-Ii was  ex- 
haustively digested with pronase and then analyzed on a sizing column of Bio-Gel P-10 (0). 
Fractions 11-15 of pronase treated, P-10 fractionated sample were pooled and, an aliquot was 
subjected to mild base hydrolysis, then re-chromatographed on the Bio-Gel P-10 column (O). 
The elution positions of hemoglobin (Hb) and free mannose (Man) are indicated. Inset SDS- 
gel profile of the anti-ll immunoprecipitate that was pronase digested. ]988  A  NEW  COMPONENT  IN  THE  MURINE  Ia  MOLECULAR COMPLEX 
column, its elution position  was unchanged (Fig.  6).  This  result rules out the 
possibility that the s'~SO4 was attached to small O-linked oligosaccharides, and 
indicates that the sulfate residues are borne on a large glycoconjugate, typical of 
proteoglycans. 
To establish that the 46-69-kdalton  molecule was indeed a proteoglycan, its 
sensitivity to enzymes that are specific for the carbohydrate units of proteoglycans 
was tested. The glycosaminoglycan components of proteoglycans consist of long 
repeating units of disaccharides consisting of a hexosamine and, with the excep- 
tion of keratan sulfate, a  uronic acid. Initial experiments (not shown) indicated 
that the 3~SO4-bearing  moiety of the Ia-associated product was degraded by the 
enzyme chondroitinase  ABC,  which  will  degrade  both  dermatan  sulfate and 
chondroitin sulfate to 4,5  unsaturated disaccharides (26).  To determine which 
class of glycosaminoglycans the molecule belong to, anti-I-A and anti-Ii immu- 
noprecipitated material from 3"~SO4-1abeled B10.A spleen cells was subjected to 
degradation by chondroitinase AC, which is specific for chondroitin sulfate. Fig. 
7  shows  the  results  of these  experiments. All  of the  sulfate-bearing  species 
associated with Ia were sensitive to chondroitinase AC, indicating that the 46- 
69-kdalton macromolecule is a proteoglycan with chondroitin sulfate glycosami- 
noglycan side chains. Paper chromatography of the digestion products (Fig.  7, 
panel C) showed that the radiolabeled material migrated at the position of the 6- 
sulfated reference disaccharide, indicating that virtually all  of the sulfation in 
this molecule occurs at the 6-position of N-acetylgalactosamine. 
Discussion 
The major histocompatibility complex (MHC) is critical in expression of the 
immune response to a  variety of antigens. In particular, evidence accumulated 
over the past 10 years indicates that genes mapping to the I region of the MHC 
play a central role in dictating the magnitude of the response to a given antigen, 
and govern the interaction of the various cell types within the immune system 
(27-30). Because of this, there has been much interest in elucidating the structure 
of products encoded within this subregion. Early studies of immunoprecipitated 
Ia molecules indicated that both the I-A and I-E subregion products consist of 
genetically polymorphic glycoprotein heterodimers composed ofa 33-35-kdalton 
chain, and a  25-27-kdalton  /3 chain  (18).  Later studies by Jones et al.  (31) 
documented that  a  third  protein,  termed invariant chain  because of its  non- 
polymorphic nature, was also present in anti-Ia immunoprecipitates. Although 
invariant chain associates specifically with Ia antigens, recent data indicate that 
the gene controlling this protein lies outside the major histocompatibility complex 
(32, 33). 
In  this  paper,  we  report  the  identification  of another  component  in  the 
oligomeric  Ia  antigen  complex--a  heterogeneous sulfated  protein-containing 
molecule migrating with  an apparent  molecular weight of 46-69-kdaltons  by 
SDS-PAGE. This product could be immunoprecipitated using antibodies specific 
[br I-A, I-E, and Ii glycoproteins, but it was not detectable in control immuno- 
precipitates, nor in  H-2K or immunoglobulin precipitates. We have also found 
this molecule in other H-2 haplotypes and thus it is not peculiar to I k mice. The 
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FIGURE 7.  Chondroitinase AC digestion of the la associated sulfated product, s~SO4-1abeled 
B 10.A spleen cell lysate was immunoprecipitated with an anti-I-A  k (Q) or anti-li (O) monoclo- 
hal antibody.  Immunoprecipitates were digested with pronase,  fractionated on Bio-Gel P-10 
and material eluting in the void volume was pooled and lyophilized to dryness. Samples were 
resuspended in 50 mM Tris HCI, pH 8 containing 0.1  mg/ml BSA. Aliquots were incubated 
in the presence or absence of chondroitinase AC then rechromatographed on Bio-Gel P-10. 
The chromatographic profile of the mock-treated samples, (panel A) and the chondroitinase- 
digested samples (panel B) are shown. An aliquot of the chondroitinase digested material was 
then analyzed by paper chromatography (panel C). Arrowheads indicate the relative migration 
of disaccharide standards  run  in adjacent lanes (from left to right: A-Di-6S,  A-Di-4S, and A. 
Di-OS). Unlabeled chondroitin sulfate, digested in parallel with the samples yielded both 4- 
and 6-sulfated disaccbarides. 
ular weight on SDS-PAGE is the same in  the presence or absence of reducing 
agents. The cellular expression of the sulfated product is similar to that observed 
for conventional Ia antigens.  It is present in Ia precipitates of splenic B cells and 
continuous B cell lines but is not detectable in Ia precipitates of splenic T  cells 
or thymocytes (manuscript in preparation). 
Preliminary  biochemical studies of the 46-69-kdahon  molecule suggested to 
us that  it  might  be a  proteoglycan.  These  studies  indicated  that  this  molecule 
was extremely heterogeneous, both in charge and apparent molecular weight, a 
common feature in proteoglycans (33). We found the molecule to be sensitive to 
proteases  but  poorly  labeled  with  methionine  and  leucine  under  short-term 
labeling  conditions.  When  pronase-digested  or  alkali-treated  material  was ex- 
amined  by gel  filtration  on  Bio-Gel  P-10,  a  single  peak  of radioactivity  was 1990  A  NEW COMPONENT IN  THE  MURINE Ia  MOLECULAR COMPLEX 
recovered,  eluting  in  the  void volume,  thus  excluding  the  possibility that  the 
35SO4 is associated with low molecular weight material such as single amino acids, 
small peptides, or glycopeptides that bear oligosaccharides typical of conventional 
glycoproteins. The results of experiments testing the susceptibility of this mole- 
cule to enzymes specific for proteoglycans confirmed our hypothesis that it was 
a  proteoglycan and  demonstrated  that  this sulfated,  Ia-associated product con- 
tains chondroitin  6-sulfate. 
An  important  point  raised  by  these  studies  is  whether  the  sulfate-labeled 
product that  we detect in  our immunoprecipitates  is reacting directly with the 
antibodies used or is precipitated only by virtue of its association with  Ia or Ii. 
This type of question is difficult to address with an oligomeric complex such as 
Ia. The most direct method would be to separate individual components in the 
complex and test for reactivity of the antibodies with the isolated molecules. A 
negative result in this experiment would be difficult to interpret,  however. Even 
with  the  conventional  Ia  heterodimer,  it  has  often  been  difficult  to  assign 
serological specificities to a  or/3 chains,  most commonly because immune reac- 
tivity is lost upon denaturation  and dissociation of the dimer.  Several points in 
our  experiments  do  bear  on  this  question,  however.  First,  we  detected  this 
molecule not only in  immunoprecipitates prepared with alloantiserum  but also 
in those prepared with monoclonal antibodies. This rules out the possibility that 
the  sulfated product  bears  MHC-encoded determinants  distinct  from  conven- 
tional Ia but reactive with antibodies other than anti-Ia that are contained within 
a complex alloantiserum.  Secondly, the monoclonai antibodies we have used are 
clearly reactive against different glycoproteins. Do3 detects Ia.7, a public speci- 
ficity on I-E molecules.  10-2.16 recognizes Ia. 17, present on I-A  k'f'r's molecules. 
In-1  reacts  with  the  nonpolymorphic  invariant  proteins  that  are  not  MHC- 
encoded.  Thus,  although  it  is possible that  the  46-69-kdalton  material  reacts 
directly with one of these antibodies, we feel it is unlikely that it reacts directly 
with all three. 
Assuming that this product is immunoprecipitated  because of its noncovalent 
interaction  with  the  Ia  complex,  it  is important  to determine  if it  is primarily 
associated with  only one  of the  glycoproteins,  i.e.,  a,  /3,  or  Ii,  and  when  and 
where this  association occurs.  Of particular  interest  is what role this  molecule 
might play in the biosynthesis of Ia,  in the formation of the a,/3,  Ii oligomeric 
complex and in the expression of Ia antigens at the plasma membrane.  Experi- 
ments designed to address these issues are currently underway in our laboratory. 
Summary 
In this report, we describe a previously unidentified component in the murine 
Ia antigen complex. SDS-PAGE analysis of anti-Ia immunoprecipitates prepared 
from spleen cells biosynthetically labeled with 35S-sulfate  showed no detectable 
incorporation of 35SO4 into a,/3, or Ii chains but did not reveal the presence of 
a novel sulfate-bearing molecule of considerable molecular weight heterogeneity 
(46-69-kdaltons). The 46-60-kdaiton molecule could be precipitated with mono- 
clonal antibodies specific for I-A,  I-E, and  Ii glycoproteins but was not seen in 
control  precipitates,  nor  in  association  with  IgG  or  class  I  MHC  molecules. 
Preliminary biochemical characterization indicated that the 46-69-kdalton prod- SANT  ET AL.  1991 
uct is extremely polydisperse, both in charge and apparent molecular weight, is 
sensitive to proteases, and bears the sulfate moiety on a  large pronase-resistant 
structure.  These  results  suggested  this  component  might  be  a  proteoglycan. 
Definitive identification of this component as a  proteoglycan was accomplished 
by selective enzymatic degradation experiments which showed that the sulfate- 
bearing component of the 46-69-kdalton molecule is chondroitin 6-sulfate. 
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